CONMED | CNMD - Selling And Administration Expenses


CONMED reported $145.55M in Selling and Administration Expenses for its fiscal quarter ending in June of 2026.





Selling And Administration Expenses Change Date
3M USD 1.06B 317M Jun/2026
Abbott USD 3.6B 330M Jun/2026
Accuray USD 124.78M 2.54M Dec/2025
AtriCure USD 82.56M 1.99M Jun/2026
Baxter International USD 735M 7M Jun/2026
Becton, Dickinson and Co. USD 1.21B 180M Mar/2026
Boston Scientific USD 1.8B 22M Jun/2026
CONMED USD 145.55M 3.85M Jun/2026
Cooper Companies USD 676.2M 303.1M Mar/2026
Dexcom USD 358.7M 9M Jun/2026
Edwards Lifesciences USD 561.2M 39M Jun/2026
Globus Medical USD 297.77M 20.7M Mar/2026
Inogen USD 43.77M 510K Jun/2024
Insulet USD 344.8M 27.6M Jun/2026
Integra LifeSciences USD 166.22M 12.01M Jun/2026
Intuitive Surgical USD 617.9M 4.6M Jun/2026
J&J USD 6.42B 381M Jun/2026
Medtronic 2.96B 9M Dec/2025
Merit Medical Systems USD 129.23M 18.76M Jun/2026
Olympus JPY 139.34B 13.69B Mar/2026
Orthofix International USD 130.35M 11.31M Dec/2025
ResMed USD 279.8M 1.4M Mar/2026
Smith & Nephew USD 1.45B 29M Jun/2026
Steris USD 351.8M 500K Mar/2026
Stryker USD 2.12B 32M Jun/2026
Tandem Diabetes Care USD 99.86M 5.34M Dec/2025
Teleflex USD 226.01M 3.64M Mar/2026
Zimmer Biomet Holdings USD 911.6M 61.7M Jun/2026